- Group page
- Research lines
- Group members
1990 PhD in Biological Sciences by the Department of Biochemistry and Molecular Biology, Autónoma University of Madrid, Spain.
1992-1996 Postdoctoral Research Associate in Joel D. Richter's laboratory, Worcester Foundation for Biomedical Research, Massachusetts, USA.
1996-2000 Postdoctoral Research Associate in Matthias W. Hentze's laboratory, European Molecular Biology Laboratory (EMBL), (Germany).
2001 Staff Scientist, European Molecular Biology Laboratory (EMBL), Germany.
2002 Group Leader at the Center for Genomic Regulation (CRG), Barcelona, Spain.
2021 Co-coordinator of the Gene Regulation, Stem Cells and Cancer Programme, Centre for Genomic Regulation (CRG), Barcelona, Spain.
Researchers reveal how skin cells form a first line of defence against cancer (11/01/2022)
A study published today in Cell Reports reveals important insights into the molecular mechanisms that underpin the body’s natural defences against the development of skin cancer.
CRG scientists will explore new treatments for Retinitis Pigmentosa and melanoma (25/07/2018)
La Caixa Banking Foundation announced today the 20 awarded projects in its 1st Health Research Call. The CRG will lead and host two of the twenty awarded projects out of the more than 780 projects that were submitted. CRG group leaders Maria Pia Cosma and Fátima Gebauer will receive funding to develop their projects, which will explore new treatments for retinal degeneration and melanoma metastasis and progression respectively.
Fátima Gebauer and Ben Lehner elected EMBO Members (16/06/2017)
Our group is interested in the regulation of mRNA translation by RNA-binding proteins (RBPs). This type of regulation is widely used in Biology to modulate processes such as metabolism, cell differentiation, embryonic patterning or synaptic transmission. We wish to understand the molecular mechanisms of translational control and the RNA networks that are established to maintain cell homeostasis. We are interested on how de-regulation of RBP function leads to disease, in particular to cancer.
Other information about the group
We acknowledge the financial contribution of the Spanish Ministry of Economy and Innovation, and the European Regional Development Fund (ERDF) to the development of the project “RNA binding proteins in translation and metastasis” (Ref. PGC2018-099697-B-I00). We also acknowledge the contribution of AGAUR (Ref. 2017SGR534), Marató-TV3 (Ref 201314), La Caixa Foundation (HR17-00232) and the Melanoma Research Alliance (Ref: 826530).